Community-Acquired Pneumonia
Cross-source consensus on Community-Acquired Pneumonia from 1 sources and 4 claims.
1 sources · 4 claims
Uses
Risks & contraindications
Evidence quality
Highlighted claims
- CAP is a leading cause of childhood hospitalisation in high-income countries and a leading cause of death among children in low- and middle-income countries. — Effectiveness of amoxicillin and amoxicillin-clavulanate for the treatment of community-acquired pneumonia in adults and children: a systematic review and meta-analysis
- The review evaluated randomized trial evidence for amoxicillin and amoxicillin-clavulanate in adults and children with CAP. — Effectiveness of amoxicillin and amoxicillin-clavulanate for the treatment of community-acquired pneumonia in adults and children: a systematic review and meta-analysis
- Community-acquired pneumonia is a major contributor to morbidity and mortality, especially among young children. — Effectiveness of amoxicillin and amoxicillin-clavulanate for the treatment of community-acquired pneumonia in adults and children: a systematic review and meta-analysis
- Empirical antibiotic guidance for CAP varies internationally and is influenced by severity and local epidemiology. — Effectiveness of amoxicillin and amoxicillin-clavulanate for the treatment of community-acquired pneumonia in adults and children: a systematic review and meta-analysis